ITCI Overview
Upcoming Projects (ITCI)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (ITCI)
-
A Third View: Looking into the data from the phase 3 Study 304 trial of Caplyta in patients with Schizophrenia.
Ticker: ITCI
Executed On: Nov 25, 2024 at 12:00 PM EST -
A Second View: Looking into the data from the phase 3 Study 304 trial of Caplyta in patients with Schizophrenia.
Ticker: ITCI
Executed On: Nov 14, 2024 at 04:30 PM EST -
Looking into the data from the phase 3 Study 304 trial of Caplyta in patients with Schizophrenia.
Ticker: ITCI
Executed On: Nov 14, 2024 at 11:00 AM EST -
A Second View: Discussing the Phase 3 topline results from study 502 looking at Lumateperone in patients with major depressive disorder
Ticker: ITCI
Executed On: Jul 18, 2024 at 11:00 AM EDT -
Discussing the Phase 3 topline results from study 502 looking at Lumateperone in patients with major depressive disorder
Ticker: ITCI
Executed On: Jul 18, 2024 at 10:30 AM EDT -
A Third Look: Perusing the Phase 3 topline results from study 501 evaluating Lumateperone in patients with major depressive disorder.
Ticker: ITCI
Executed On: Apr 26, 2024 at 01:00 PM EDT -
A Second Look: Perusing the Phase 3 topline results from study 501 evaluating Lumateperone in patients with major depressive disorder.
Ticker: ITCI
Executed On: Apr 25, 2024 at 01:30 PM EDT -
Perusing the Phase 3 topline results from study 501 evaluating Lumateperone in patients with major depressive disorder.
Ticker: ITCI
Executed On: Apr 24, 2024 at 03:00 PM EDT -
A Third Look: Reviewing the standard of care for bipolar depression and the use of Auvelity and Caplyta
Tickers: AXSM, ITCI
Executed On: Nov 17, 2023 at 12:00 PM EST -
A Second Look: Reviewing the standard of care for bipolar depression and the use of Auvelity and Caplyta
Tickers: AXSM, ITCI
Executed On: Nov 09, 2023 at 10:30 AM EST -
Reviewing the standard of care for bipolar depression and the use of Auvelity and Caplyta
Tickers: AXSM, ITCI
Executed On: Nov 09, 2023 at 08:15 AM EST -
Digging into the recent topline results from Study 403 evaluating CAPLYTA (lumateperone) by Intra-Cellular Therapies as a monotherapy in patients with Major Depressive Disorder and Bipolar Depression
Ticker: ITCI
Executed On: Apr 03, 2023 at 03:00 PM EDT -
A First look at the safety and efficacy of Lumateperon in treating bipolar depression.
Ticker: ITCI
Executed On: Nov 10, 2022 at 11:15 AM EST -
Check-in on prescribing pattern of Caplyta in treating patients with schizophrenia
Ticker: ITCI
Executed On: Nov 08, 2022 at 03:00 PM EST
Upcoming & Overdue Catalysts (ITCI)
-
Don’t see a catalyst related to the company you care about? Create your own!
Strategic Initiatives (ITCI)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
